APUS vs U · $2.4M cap vs rev $1.85B
Apimeds Pharmaceuticals US, Inc. (APUS) versus Unity Software Inc (U) — a side-by-side from cached financials, not a winner call.
Apimeds Pharmaceuticals US, Inc. (APUS) is a drug manufacturers - specialty & generic company listed on US.
Unity Software Inc (U) is a software - application company listed on US.
APUS does not have a complete income-statement cache yet.
Latest reported U revenue for 2025-12-31 was $1.85B. Net income was -$402.8M. Revenue was up 2.0% from 2024-12-31 to 2025-12-31. U currently screens at market cap $16.98B.
APUS currently screens at market cap $2.4M. U currently screens at market cap $16.98B.
Not investment advice. Open the APUS and U stock pages for the full models.
Not investment advice.